Abstract CT198: Immunomodulatory effects of the ATR inhibitor ceralasertib in a window of opportunity biomarker trial in patients with head and neck squamous cell carcinomaGemma N. Jones, Umamaheswar Duvvuri, Marta Milo et al.|Cancer Research|2023Cited by 3